| 1 | [SID17409043] | Active | Potency | 0.5358 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 0.5358 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 2 | [SID56373716] | Active | IC50 | 1.38 | SAR analysis of the MOA of E2 SUMOylation inhibitors in an HTRF format [AID485393, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56373716 | | CID | 6874905 | | Outcome | Active | | IC50 | 1.38 [uM] | | BioAssay | SAR analysis of the MOA of E2 SUMOylation inhibitors in an HTRF format | | AID | 485393 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 3 | [SID17409043] | Active | IC50 | 1.66718 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 1.66718 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 4 | [SID17409043] | Active | IC50 | 1.66718 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 1.66718 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 5 | [SID17409043] | Active | IC50 | 1.66718 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 1.66718 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 6 | [SID85256229] | Active | IC50 | 1.83 | SAR analysis of the MOA of E2 SUMOylation inhibitors in an HTRF format [AID485393, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85256229 | | CID | 6874905 | | Outcome | Active | | IC50 | 1.83 [uM] | | BioAssay | SAR analysis of the MOA of E2 SUMOylation inhibitors in an HTRF format | | AID | 485393 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 7 | [SID17409043] | Active | Potency | 2.2387 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 8 | [SID17409043] | Active | Potency | 2.2387 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 9 | [SID17409043] | Active | IC50 | 2.253 | TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2) [AID1641, Type: confirmatory] | PTK2B protein tyrosine kinase 2 beta [Homo sapiens] [gi:34784998] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 2.253 [uM] | | BioAssay | TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2) | | AID | 1641 | | BioAssay type | confirmatory | | Target | PTK2B protein tyrosine kinase 2 beta [Homo sapiens] [gi:34784998] | | PubMed | | | Data Table |  |
|
| 10 | [SID17409043] | Active | IC50 | 2.253 | TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2) [AID1641, Type: confirmatory] | PTK2B protein tyrosine kinase 2 beta [Homo sapiens] [gi:34784998] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 2.253 [uM] | | BioAssay | TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2) | | AID | 1641 | | BioAssay type | confirmatory | | Target | PTK2B protein tyrosine kinase 2 beta [Homo sapiens] [gi:34784998] | | PubMed | | | Data Table |  |
|
| 11 | [SID17409043] | Active | IC50 | 2.253 | TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2) [AID1641, Type: confirmatory] | PTK2B protein tyrosine kinase 2 beta [Homo sapiens] [gi:34784998] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 2.253 [uM] | | BioAssay | TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2) | | AID | 1641 | | BioAssay type | confirmatory | | Target | PTK2B protein tyrosine kinase 2 beta [Homo sapiens] [gi:34784998] | | PubMed | | | Data Table |  |
|
| 12 | [SID17409043] | Active | IC50 | 3.18 | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 3.18 [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 13 | [SID17409043] | Active | IC50 | 3.61 | Dose Response Confirmation for Small Molecule Inhibitors of Epstein-Barr Virus [AID1419, Type: confirmatory] | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 3.61 [uM] | | BioAssay | Dose Response Confirmation for Small Molecule Inhibitors of Epstein-Barr Virus | | AID | 1419 | | BioAssay type | confirmatory | | Target | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] | | PubMed | | | Data Table |  |
|
| 14 | [SID17409043] | Active | Potency | 4.4668 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 15 | [SID85256229] | Active | IC50 | 4.79 | SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF - Set 2 [AID434980, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85256229 | | CID | 6874905 | | Outcome | Active | | IC50 | 4.79 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF - Set 2 | | AID | 434980 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 16 | [SID17409043] | Active | IC50 | 4.81 | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602386, Type: confirmatory] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 4.81 [uM] | | BioAssay | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602386 | | BioAssay type | confirmatory | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 17 | [SID17409043] | Active | IC50 | 4.81 | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602386, Type: confirmatory] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 4.81 [uM] | | BioAssay | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602386 | | BioAssay type | confirmatory | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 18 | [SID17409043] | Active | Potency | 5.6234 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 19 | [SID17409043] | Active | Potency | 5.6234 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 20 | [SID17409043] | Active | Potency | 5.7591 | qHTS Confirmation Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2585, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 5.7591 [uM] | | BioAssay | qHTS Confirmation Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2585 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 21 | [SID17409043] | Active | Potency | 5.7988 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 5.7988 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 22 | [SID17409043] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 23 | [SID56373716] | Active | IC50 | 7.16 | SAR analysis of SUMOylation using HTRF in an in-Vitro dose response assay [AID2614, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56373716 | | CID | 6874905 | | Outcome | Active | | IC50 | 7.16 [uM] | | BioAssay | SAR analysis of SUMOylation using HTRF in an in-Vitro dose response assay | | AID | 2614 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 24 | [SID17409043] | Active | IC50 | 7.186 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2217, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 7.186 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2217 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 25 | [SID17409043] | Active | IC50 | 7.186 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2217, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 7.186 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2217 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 26 | [SID17409043] | Active | IC50 | 7.186 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2217, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 7.186 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2217 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 27 | [SID17409043] | Active | IC50 | 7.33 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624317, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 7.33 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624317 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 28 | [SID17409043] | Active | IC50 | 8.21 | uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2091, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 8.21 [uM] | | BioAssay | uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2091 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 29 | [SID85256229] | Active | IC50 | 8.96 | SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF [AID2489, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85256229 | | CID | 6874905 | | Outcome | Active | | IC50 | 8.96 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF | | AID | 2489 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 30 | [SID85256229] | Active | IC50 | 9.07 | SAR analysis of SUMOylation using HTRF in an in-Vitro dose response assay [AID2614, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85256229 | | CID | 6874905 | | Outcome | Active | | IC50 | 9.07 [uM] | | BioAssay | SAR analysis of SUMOylation using HTRF in an in-Vitro dose response assay | | AID | 2614 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 31 | [SID17409043] | Active | Potency | 10.3225 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 32 | [SID17409043] | Active | Potency | 10.3225 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 33 | [SID17409043] | Active | Potency | 10.3225 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 34 | [SID17409043] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 35 | [SID17409043] | Active | Potency | 12.5893 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 36 | [SID56373716] | Active | IC50 | 12.9 | SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF - Set 2 [AID434980, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56373716 | | CID | 6874905 | | Outcome | Active | | IC50 | 12.9 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF - Set 2 | | AID | 434980 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 37 | [SID17409043] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 38 | [SID17409043] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 39 | [SID17409043] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 40 | [SID17409043] | Active | Potency | 16.3601 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID17409043] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 42 | [SID17409043] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 43 | [SID17409043] | Active | IC50 | 21.1 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 [AID651709, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | IC50 | 21.1 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 | | AID | 651709 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 44 | [SID17409043] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 45 | [SID85256229] | Active | IC50 | 23.3 | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies [AID2658, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85256229 | | CID | 6874905 | | Outcome | Active | | IC50 | 23.3 [uM] | | BioAssay | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies | | AID | 2658 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 46 | [SID85256229] | Active | IC50 | 23.3 | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies [AID2658, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85256229 | | CID | 6874905 | | Outcome | Active | | IC50 | 23.3 [uM] | | BioAssay | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies | | AID | 2658 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 47 | [SID56373716] | Active | IC50 | 25.8 | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies [AID2658, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56373716 | | CID | 6874905 | | Outcome | Active | | IC50 | 25.8 [uM] | | BioAssay | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies | | AID | 2658 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 48 | [SID56373716] | Active | IC50 | 25.8 | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies [AID2658, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56373716 | | CID | 6874905 | | Outcome | Active | | IC50 | 25.8 [uM] | | BioAssay | SAR analysis of Ubc13-Ubiquitination selectivity in a TR-FRET assay for In Vitro dose response studies | | AID | 2658 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 49 | [SID17409043] | Active | Potency | 28.1838 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 50 | [SID17409043] | Active | Potency | 28.1838 | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2708, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17409043 | | CID | 6874905 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2708 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|